반응 #336539

ord-a30a3ee83f0a412cbb2dc1040ae65e4a

반응 방정식

ClCn1cnc(Cl)c1Cl
N-(1-chloromethyl)-4,5-dichloroimidazole
[H-].[Na+]
sodium hydride
Oc1ccc(Oc2ccccc2)cc1
4-phenoxyphenol
[H][H]
hydrogen
Clc1ncn(COc2ccc(Oc3ccccc3)cc2)c1Cl
N-[(p-phenoxyphenoxy)-methyl]-4,5-dichloroimidazole

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타(about 1 hour)
  2. 2
    추출followed by extraction three times with methyl tert-butyl ether
  3. 3
    세척The combined organic phases are washed three times with water
  4. 4
    건조dried over sodium sulfate
  5. 5
    기타The solid residue is recrystallized from n-pentane/ether (6:1)

실험 절차

9.3 g of 4-phenoxyphenol is dissolved in 60 ml of anhydrous dimethylformamide. 1.58 g of 80% strength sodium hydride is added, and the mixture is heated at 60° C. until no more hydrogen evolves (about 1 hour). A solution of 9.28 g of N-(1-chloromethyl)-4,5-dichloroimidazole in 30 ml of dimethylformamide is then dripped in. The mixture is stirred overnight at room temperature, after which it is poured into 500 ml of water, followed by extraction three times with methyl tert-butyl ether. The combined organic phases are washed three times with water, dried over sodium sulfate, and freed from solvent under reduced pressure. The solid residue is recrystallized from n-pentane/ether (6:1) to give N-[(p-phenoxyphenoxy)-methyl]-4,5-dichloroimidazole, m.p.: 82°-83° C.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US05214064uspto-grants-1993_05